Anti-COVID-19 epidemic products made in GDD enter global stage

The detection reagent products for the novel coronavirus (COVID-19) manufactured by biomedicine companies in Guangzhou Development District have entered the global stage in less than five months after their creation due to the strong local technical power.

Daan Gene was the first company in Guangdong and one of the earliest in China to launch its nucleic acid detection kit for the COVID-19, doing so on Jan 13, one day after the release of the genome sequence of the COVID-19.

The company then entered the green channel for fast approval offered by the National Medical Products Administration and acquired the medical device registration certificate on Jan 28.

The daily production capacity of testing kits of Daan Gene has reached an average of 300,000 by April 7.

Zhang Bin, deputy general manager of Daan Gene, listed two reasons for the company's quick research and manufacturing, noting that the company independently holds all its core techniques and raw materials, as well as that GDD owns a complete industrial chain in biomedicine.

Guangzhou Wondfo Biotech Co Ltd has seen rapid increases in overseas orders for products like testing kits and equipment. By the end of the first quarter of the year, the company has received orders from more than 20 countries and regions around the world like South Korea, Germany, Italy, and Brazil.

Zhao Yaping, rotating president of Wondfo, noted that the company values exporting whole anti-epidemic solutions to overseas areas over simply exporting medical products.

Daan Gene is able to produce an average of 300,000 testing kits per day as of April 7.

Share - WeChat